Facebook Linkedin Mail Twitter
Facebook Linkedin Mail Twitter

Tag: OptaBlate

Stryker receives FDA clearance for OptaBlate bone tumour ablation system

Stryker has announced that its first interventional oncology technology, the OptaBlate bone tumour ablation system, has received 510(k) clearance from the US Food and...
Spinal News International

Write to us
Editor: Jamie Bell [email protected]
Advertising: Michael Broughton [email protected]


United Kingdom:

BIBA Medical, Europe
526 Fulham Road, Fulham, London, SW6 5NR
TEL: +44 (0)20 7736 8788
Email: [email protected]

United States:

BIBA Medical, North America
155 North Wacker Drive, Suite 4250, Chicago, IL 60606
TEL: +1 949 723 9309
Email: [email protected]

Terms and Conditions | Privacy Policy

Facebook Linkedin Mail Twitter